You are here

Drug Forecast

Memantine: A New Treatment Option for Patients with Moderate-to-Severe Alzheimer’s Disease

Yvonne Ho, PharmD Candidate, and Larisa Chagan, BS, PharmD, BCPS
PDF version: 
Yvonne Ho and Larisa Chagan review memantine (Namenda™) for moderate-to-severe Alzheimer’s disease.